(HealthDay News) – There is an inverse association between levels of 25-hydroxyvitamin D (25[OH]D) and the risk of multiple sclerosis (MS), but no association between gestational levels of 25(OH)D and offspring risk of MS, according to a study published in the Nov. 20 issue of Neurology.

Jonatan Salzer, MD, from Umeå University in Sweden, and colleagues examined the correlation between vitamin D levels and MS risk using data from a nested case-control study involving two population-based biobanks with 291,500 samples from 164,000 individuals collected since 1975. Blood samples were identified from MS cases (192, with controls matched in a 2:1 ratio) and gestational samples were collected from pregnant women whose offspring later developed MS (37, matched with control mothers in a 5:1 ratio).

The researchers found that levels of 25(OH)D ≥75nmol/L correlated with a significantly decreased risk of MS compared with levels <75nmol/L (odds ratio, 0.39). Offspring exposed to gestational 25(OH)D levels of ≥75nmol/L vs. <75nmol/L had no significantly decreased risk of MS (odds ratio, 1.8; 95% confidence interval, 0.53–5.8). During 1976–2005, the prevalence of 25(OH)D ≥75nmol/L gradually decreased in controls.

“This study gives further support for the association between vitamin D status and MS,” the authors write. “Our data suggest that vitamin D may act as a protective factor for MS somewhere between late pregnancy and young adulthood.”


Continue Reading

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)